As SARS-CoV-2 continues to evolve, variants such as Omicron demonstrate increased transmissibility and altered clinical profiles. Symptoms range from asymptomatic carriage to severe pneumonia, ARDS, sepsis, and death, with the elderly and those with pre-existing conditions at greatest risk. Accurate, rapid detection remains critical not only for individual patient management but also for variant surveillance and public health decision-making. Single-gene assays risk variant-related detection failures, underscoring the need for a multi-target approach.
The COVIDtect Multiplex RT-PCR Kit from Genes2Me delivers precise detection of SARS-CoV-2 across all major variants in a single assay. By targeting three viral genes simultaneously and enabling Omicron differentiation via S gene dropout, it provides comprehensive, variant-aware results directly from nasopharyngeal and oropharyngeal swabs.
Genes2Me is a CE Marked molecular diagnostics company trusted by clinical laboratories across global markets. The COVIDtect Multiplex RT-PCR Kit meets European conformity standards for in vitro diagnostic devices, validated to international benchmarks for accuracy, reliability, and safety
The COVIDtect kit uses multiplex real-time reverse-transcription PCR to simultaneously target three SARS-CoV-2 genomic regions: the RdRp gene, the N gene, and the S gene. S gene dropout in the context of a positive result indicates the presence of the Omicron variant. Human RNaseP serves as an internal control, monitoring PCR inhibition and validating extraction and amplification in every run. A complete reagent set including positive control template is supplied, supporting a seamless and contamination-free workflow.
As SARS-CoV-2 continues to mutate, single-gene assays are increasingly vulnerable to variant-related detection gaps. Targeting three genes simultaneously ensures that no single mutation can cause a missed positive, while S gene dropout provides actionable variant-level information without the need for separate sequencing. A built-in internal control further guards against false negatives from PCR inhibition, delivering results that clinicians and public health teams can act on with confidence.
Targets RdRp, N, and S genes of SARS-CoV-2 simultaneously, ensuring high specificity, sensitivity, and the ability to differentiate the Omicron variant via S gene dropout.
S gene dropout pattern enables identification of Omicron alongside other SARS-CoV-2 variants, supporting variant-aware clinical and epidemiological decision-making.
Monitors PCR inhibition and validates extraction and amplification, minimising the risk of false-negative results across all samples.
Primer and probe mixes, OneStep qRT-PCR master mix, positive control template, and RNase/DNase-free water are all supplied for a seamless, contamination-free workflow.
Validated on RapiCycler 96, Bio-Rad CFX96, QuantStudio 5, and LightCycler 480.
Results available within hours, with a Ct cut-off of 35 or below ensuring robust detection even in samples with low SARS-CoV-2 viral loads.
| Commercial Name | Old Cat No. | New Cat No. | Pack Size |
|---|---|---|---|
| COVIDtect Multiplex RT-PCR Kit | G2M030321R | 50 Tests |
Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.
© 2025 Genes2me. All rights reserved.
